RM LATEST
(2026/2027)//APEA-
2025 REVISED EXAM
ENDOCRINE
QUESTIONS
PHARM
ANDLATEST
CORRECT
2025DETAILED
REVISED ANSWERS
EXAM
PageQUESTIONS
1 of (VERIFIED
49 AND
COMPLETE
CORRECTSOLUTION)
DETAILED ALREADY
ANSWERSPASSED
(VERIFIED
SCORE
COMPLETE
A+.pdf SOLUTI
APEA- ENDOCRINE PHARM LATEST
2025 REVISED EXAM QUESTIONS
AND CORRECT DETAILED ANSWERS
(VERIFIED COMPLETE SOLUTION)
ALREADY PASSED SCORE A+
10 minutes prior to a meal
Aspart (NovoLog) should be administered:
10 minutes prior to a meal.
30 minutes prior to a meal.
30 minutes after a meal.
just before sleep.
15 minutes.
AM
ENDOCRINE
QUESTIONS
ExamPHARM
Q&A
AND(2026/2027)
CORRECT
LATEST 2025
| DETAILED
Complete
REVISEDStudy
ANSWERS
EXAM
Guide
QUESTIONS
&
(VERIFIED
Verified Questions
AND
COMPLETE
CORRECT
withSOLUTION)
Correct
DETAILED
AnswersPage
ALREADY
ANSWERS1PASSED
of(VERIFIED
49 SCORE COMPLETE
A+.pdfQ&A
SOLUTION)
with Rationales
ALREADY
2026/2027
PASSED SCO
,RM LATEST
(2026/2027)//APEA-
2025 REVISED EXAM
ENDOCRINE
QUESTIONS
PHARM
ANDLATEST
CORRECT
2025DETAILED
REVISED ANSWERS
EXAM
PageQUESTIONS
2 of (VERIFIED
49 AND
COMPLETE
CORRECTSOLUTION)
DETAILED ALREADY
ANSWERSPASSED
(VERIFIED
SCORE
COMPLETE
A+.pdf SOLUTI
The maximum plasma concentration of glucagon, after intramuscular
administration to a patient with severe hypoglycemia, are obtained in
approximately 13 minutes
Maximum plasma concentrations of glucagon, after intramuscular injection, are
observed in approximately:
5 minutes.
15 minutes.
30 minutes.
45 minutes.
avoid contact with young children for several days.
Patients who receive radioiodine have the potential to expose their home and
household contacts via saliva and urine due to radiation emitting from their body.
Patients must take radiation precautions for several days after treatment,
avoiding contact with young children and pregnant women.
Patients who are receiving radioiodine therapy for hyperthyroidism should be
advised to:
avoid contact with young children for several days.
avoid becoming pregnant during treatment and for 12 months after treatment.
expect hair loss over the next 3 months.
monitor for laryngeal damage.
AM
ENDOCRINE
QUESTIONS
ExamPHARM
Q&A
AND(2026/2027)
CORRECT
LATEST 2025
| DETAILED
Complete
REVISEDStudy
ANSWERS
EXAM
Guide
QUESTIONS
&
(VERIFIED
Verified Questions
AND
COMPLETE
CORRECT
withSOLUTION)
Correct
DETAILED
AnswersPage
ALREADY
ANSWERS2PASSED
of(VERIFIED
49 SCORE COMPLETE
A+.pdfQ&A
SOLUTION)
with Rationales
ALREADY
2026/2027
PASSED SCO
,RM LATEST
(2026/2027)//APEA-
2025 REVISED EXAM
ENDOCRINE
QUESTIONS
PHARM
ANDLATEST
CORRECT
2025DETAILED
REVISED ANSWERS
EXAM
PageQUESTIONS
3 of (VERIFIED
49 AND
COMPLETE
CORRECTSOLUTION)
DETAILED ALREADY
ANSWERSPASSED
(VERIFIED
SCORE
COMPLETE
A+.pdf SOLUTI
twice daily, within 1 hour prior to morning and evening meals.
Patients should be instructed to administer exenatide (Byetta) within 60 minutes
prior to the morning and evening meal (or prior to the 2 main meals of the day).
Injections should be administered approximately =6 hours apart
Because of the mechanism of action, patients should be instructed to administer
exenatide (Byetta):
daily at bedtime.
immediately following the largest meal of the day.
twice daily, within 1 hour prior to morning and evening meals.
at least 12 hours apart, regardless of meals.
10 units of Humulin R U-500 is equal to 10 units on a U-500 insulin syringe.
For safety, ONLY the U-500 syringe should be used. It is not recommended for use
in insulin pumps due to possibility of precipitation.
When patients administer regular insulin (Humulin R U-500), they should be
taught:
5 units of Humulin R U-500 is equal to 10 units on a U-100 insulin syringe.
10 units of Humulin R U-500 is equal to 5 units on a U-100 insulin syringe.
10 units of Humulin R U-500 is equal to 10 units on a U-500 insulin syringe.
AM
ENDOCRINE
QUESTIONS
ExamPHARM
Q&A
AND(2026/2027)
CORRECT
LATEST 2025
| DETAILED
Complete
REVISEDStudy
ANSWERS
EXAM
Guide
QUESTIONS
&
(VERIFIED
Verified Questions
AND
COMPLETE
CORRECT
withSOLUTION)
Correct
DETAILED
AnswersPage
ALREADY
ANSWERS3PASSED
of(VERIFIED
49 SCORE COMPLETE
A+.pdfQ&A
SOLUTION)
with Rationales
ALREADY
2026/2027
PASSED SCO
,RM LATEST
(2026/2027)//APEA-
2025 REVISED EXAM
ENDOCRINE
QUESTIONS
PHARM
ANDLATEST
CORRECT
2025DETAILED
REVISED ANSWERS
EXAM
PageQUESTIONS
4 of (VERIFIED
49 AND
COMPLETE
CORRECTSOLUTION)
DETAILED ALREADY
ANSWERSPASSED
(VERIFIED
SCORE
COMPLETE
A+.pdf SOLUTI
it should only be used in an insulin pump.
highly efficacious with moderate risk of hypoglycemia.
Because the effect of these 2 medications in combination is additive, together
they can potentially decrease A1C 2-4%. This is considered highly efficacious.
The combination of metformin (Glucophage) and glyburide (Diabeta) for the
treatment of Type 2 diabetes is:
moderately efficacious with low risk of hypoglycemia.
moderately efficacious with high risk of hypoglycemia.
highly efficacious with moderate risk of hypoglycemia.
highly efficacious with low risk of hypoglycemia.
pediatric patients with Type 2 diabetes mellitus.
The FDA has not approved Lantus for use in children with Type 2 diabetes.
Insulin glargine (Lantus) is NOT indicated in the treatment of:
adults with Type 1 diabetes mellitus.
adults with Type 2 diabetes mellitus.
pediatric patients with Type 1 diabetes mellitus.
pediatric patients with Type 2 diabetes mellitus.
AM
ENDOCRINE
QUESTIONS
ExamPHARM
Q&A
AND(2026/2027)
CORRECT
LATEST 2025
| DETAILED
Complete
REVISEDStudy
ANSWERS
EXAM
Guide
QUESTIONS
&
(VERIFIED
Verified Questions
AND
COMPLETE
CORRECT
withSOLUTION)
Correct
DETAILED
AnswersPage
ALREADY
ANSWERS4PASSED
of(VERIFIED
49 SCORE COMPLETE
A+.pdfQ&A
SOLUTION)
with Rationales
ALREADY
2026/2027
PASSED SCO
(2026/2027)//APEA-
2025 REVISED EXAM
ENDOCRINE
QUESTIONS
PHARM
ANDLATEST
CORRECT
2025DETAILED
REVISED ANSWERS
EXAM
PageQUESTIONS
1 of (VERIFIED
49 AND
COMPLETE
CORRECTSOLUTION)
DETAILED ALREADY
ANSWERSPASSED
(VERIFIED
SCORE
COMPLETE
A+.pdf SOLUTI
APEA- ENDOCRINE PHARM LATEST
2025 REVISED EXAM QUESTIONS
AND CORRECT DETAILED ANSWERS
(VERIFIED COMPLETE SOLUTION)
ALREADY PASSED SCORE A+
10 minutes prior to a meal
Aspart (NovoLog) should be administered:
10 minutes prior to a meal.
30 minutes prior to a meal.
30 minutes after a meal.
just before sleep.
15 minutes.
AM
ENDOCRINE
QUESTIONS
ExamPHARM
Q&A
AND(2026/2027)
CORRECT
LATEST 2025
| DETAILED
Complete
REVISEDStudy
ANSWERS
EXAM
Guide
QUESTIONS
&
(VERIFIED
Verified Questions
AND
COMPLETE
CORRECT
withSOLUTION)
Correct
DETAILED
AnswersPage
ALREADY
ANSWERS1PASSED
of(VERIFIED
49 SCORE COMPLETE
A+.pdfQ&A
SOLUTION)
with Rationales
ALREADY
2026/2027
PASSED SCO
,RM LATEST
(2026/2027)//APEA-
2025 REVISED EXAM
ENDOCRINE
QUESTIONS
PHARM
ANDLATEST
CORRECT
2025DETAILED
REVISED ANSWERS
EXAM
PageQUESTIONS
2 of (VERIFIED
49 AND
COMPLETE
CORRECTSOLUTION)
DETAILED ALREADY
ANSWERSPASSED
(VERIFIED
SCORE
COMPLETE
A+.pdf SOLUTI
The maximum plasma concentration of glucagon, after intramuscular
administration to a patient with severe hypoglycemia, are obtained in
approximately 13 minutes
Maximum plasma concentrations of glucagon, after intramuscular injection, are
observed in approximately:
5 minutes.
15 minutes.
30 minutes.
45 minutes.
avoid contact with young children for several days.
Patients who receive radioiodine have the potential to expose their home and
household contacts via saliva and urine due to radiation emitting from their body.
Patients must take radiation precautions for several days after treatment,
avoiding contact with young children and pregnant women.
Patients who are receiving radioiodine therapy for hyperthyroidism should be
advised to:
avoid contact with young children for several days.
avoid becoming pregnant during treatment and for 12 months after treatment.
expect hair loss over the next 3 months.
monitor for laryngeal damage.
AM
ENDOCRINE
QUESTIONS
ExamPHARM
Q&A
AND(2026/2027)
CORRECT
LATEST 2025
| DETAILED
Complete
REVISEDStudy
ANSWERS
EXAM
Guide
QUESTIONS
&
(VERIFIED
Verified Questions
AND
COMPLETE
CORRECT
withSOLUTION)
Correct
DETAILED
AnswersPage
ALREADY
ANSWERS2PASSED
of(VERIFIED
49 SCORE COMPLETE
A+.pdfQ&A
SOLUTION)
with Rationales
ALREADY
2026/2027
PASSED SCO
,RM LATEST
(2026/2027)//APEA-
2025 REVISED EXAM
ENDOCRINE
QUESTIONS
PHARM
ANDLATEST
CORRECT
2025DETAILED
REVISED ANSWERS
EXAM
PageQUESTIONS
3 of (VERIFIED
49 AND
COMPLETE
CORRECTSOLUTION)
DETAILED ALREADY
ANSWERSPASSED
(VERIFIED
SCORE
COMPLETE
A+.pdf SOLUTI
twice daily, within 1 hour prior to morning and evening meals.
Patients should be instructed to administer exenatide (Byetta) within 60 minutes
prior to the morning and evening meal (or prior to the 2 main meals of the day).
Injections should be administered approximately =6 hours apart
Because of the mechanism of action, patients should be instructed to administer
exenatide (Byetta):
daily at bedtime.
immediately following the largest meal of the day.
twice daily, within 1 hour prior to morning and evening meals.
at least 12 hours apart, regardless of meals.
10 units of Humulin R U-500 is equal to 10 units on a U-500 insulin syringe.
For safety, ONLY the U-500 syringe should be used. It is not recommended for use
in insulin pumps due to possibility of precipitation.
When patients administer regular insulin (Humulin R U-500), they should be
taught:
5 units of Humulin R U-500 is equal to 10 units on a U-100 insulin syringe.
10 units of Humulin R U-500 is equal to 5 units on a U-100 insulin syringe.
10 units of Humulin R U-500 is equal to 10 units on a U-500 insulin syringe.
AM
ENDOCRINE
QUESTIONS
ExamPHARM
Q&A
AND(2026/2027)
CORRECT
LATEST 2025
| DETAILED
Complete
REVISEDStudy
ANSWERS
EXAM
Guide
QUESTIONS
&
(VERIFIED
Verified Questions
AND
COMPLETE
CORRECT
withSOLUTION)
Correct
DETAILED
AnswersPage
ALREADY
ANSWERS3PASSED
of(VERIFIED
49 SCORE COMPLETE
A+.pdfQ&A
SOLUTION)
with Rationales
ALREADY
2026/2027
PASSED SCO
,RM LATEST
(2026/2027)//APEA-
2025 REVISED EXAM
ENDOCRINE
QUESTIONS
PHARM
ANDLATEST
CORRECT
2025DETAILED
REVISED ANSWERS
EXAM
PageQUESTIONS
4 of (VERIFIED
49 AND
COMPLETE
CORRECTSOLUTION)
DETAILED ALREADY
ANSWERSPASSED
(VERIFIED
SCORE
COMPLETE
A+.pdf SOLUTI
it should only be used in an insulin pump.
highly efficacious with moderate risk of hypoglycemia.
Because the effect of these 2 medications in combination is additive, together
they can potentially decrease A1C 2-4%. This is considered highly efficacious.
The combination of metformin (Glucophage) and glyburide (Diabeta) for the
treatment of Type 2 diabetes is:
moderately efficacious with low risk of hypoglycemia.
moderately efficacious with high risk of hypoglycemia.
highly efficacious with moderate risk of hypoglycemia.
highly efficacious with low risk of hypoglycemia.
pediatric patients with Type 2 diabetes mellitus.
The FDA has not approved Lantus for use in children with Type 2 diabetes.
Insulin glargine (Lantus) is NOT indicated in the treatment of:
adults with Type 1 diabetes mellitus.
adults with Type 2 diabetes mellitus.
pediatric patients with Type 1 diabetes mellitus.
pediatric patients with Type 2 diabetes mellitus.
AM
ENDOCRINE
QUESTIONS
ExamPHARM
Q&A
AND(2026/2027)
CORRECT
LATEST 2025
| DETAILED
Complete
REVISEDStudy
ANSWERS
EXAM
Guide
QUESTIONS
&
(VERIFIED
Verified Questions
AND
COMPLETE
CORRECT
withSOLUTION)
Correct
DETAILED
AnswersPage
ALREADY
ANSWERS4PASSED
of(VERIFIED
49 SCORE COMPLETE
A+.pdfQ&A
SOLUTION)
with Rationales
ALREADY
2026/2027
PASSED SCO
